SEC Form 4 · accession 0000899243-15-008853
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael D. Mulholland
Officer — CFO, Treasurer and Secretary
Period of report
Nov 23, 2015
Accepted (ET)
Nov 25, 2015 · 6:08 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (right to buy)F1 | $0.87 | Nov 23, 2015 | A | 500,000 | A | — | Nov 23, 2025 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1The options vest upon the achievement of certain strategic milestones specified in the award agreement.